Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Video

Updated: Jul 11, 2026

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice
07:46

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice

Published on: October 6, 2023

Stem cell therapy and the retina.

R E MacLaren1, R A Pearson

  • 1Vitreoretinal Service, Moorfields Eye Hospital, London, UK. mol.therapy@ucl.ac.uk

Eye (London, England)
|October 5, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

iPS Cell Differentiation01:22

iPS Cell Differentiation

The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
Stem Cell Therapy for Tissue Regeneration01:21

Stem Cell Therapy for Tissue Regeneration

Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
Induced Pluripotent Stem Cells01:13

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different types of cells. Ordinarily, cells that have differentiated into a specific cell type are post-mitotic—that is, they no longer divide. However, scientists have found a way to reprogram these mature cells so that they “de-differentiate” and return to an unspecialized, proliferative state. These cells are also pluripotent like embryonic stem cells—able to produce all cell types—and are therefore called induced pluripotent stem...
Induced Pluripotent Stem Cells01:06

Induced Pluripotent Stem Cells

Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic cells are...
Stem Cell Culture01:17

Stem Cell Culture

Stem cell research aims to find ways to use stem cells to regenerate and repair cellular damage. Over time, most adult cells undergo the wear and tear of aging and lose their ability to divide and repair themselves. Stem cells do not display a particular morphology or function. Adult stem cells, which exist as a small subset of cells in most tissues, keep dividing and can differentiate into a number of specialized cells generally formed by that tissue. These cells enable the body to renew and...
Embryonic Stem Cells00:57

Embryonic Stem Cells

Embryonic stem (ES) cells were first discovered in mice in 1981 by Martin Evans. In 1998, James Thomson identified a method to isolate embryonic stem cells from humans. Human embryonic stem cells (hESCs) are obtained from 3-5 day old embryos that remain unused after an in vitro fertilization procedure.
ES cells are grown in a culture medium where they can divide indefinitely, creating ES cell lines. Under certain conditions, ES cells can differentiate, either spontaneously into a variety of...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Verification imaging in prostate MR-only radiotherapy: Are fiducial markers necessary?

Radiography (London, England : 1995)·2024
Same author

Author Correction: Restoration of vision after transplantation of photoreceptors.

Nature·2024
Same author

The first patients treated with MR-CBCT soft-tissue matching in a MR-only prostate radiotherapy pathway.

Radiography (London, England : 1995)·2023
Same author

Pure Milk.

The Journal of comparative medicine and veterinary archives·2022
Same author

Pure Milk.

The Journal of comparative medicine and veterinary archives·2022
Same author

Envisioning the development of a CRISPR-Cas mediated base editing strategy for a patient with a novel pathogenic <i>CRB1</i> single nucleotide variant.

Ophthalmic genetics·2022

Replacing lost photoreceptors through cell transplantation offers hope for treating blindness. Optimizing stem cells for transplantation and understanding their differentiation are key to successful retinal repair strategies.

Area of Science:

  • Ophthalmology
  • Regenerative Medicine
  • Cell Biology

Background:

  • Retinal degeneration leads to photoreceptor loss, a primary cause of untreatable blindness.
  • Current strategies for retinal repair focus on cell transplantation using stem cells.
  • Challenges remain in optimizing donor cells and transplantation techniques for clinical application.

Purpose of the Study:

  • To review advances in photoreceptor replacement strategies via cell transplantation.
  • To discuss the optimization of stem cells for retinal repair.
  • To explore the potential of stem cell and cloning biology in clinical retinal strategies.

Main Methods:

  • Review of current human and animal models of retinal cell transplantation.
  • Focus on stem cell and reproductive cloning biology.

More Related Videos

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models
11:29

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models

Published on: September 6, 2018

Related Experiment Videos

Last Updated: Jul 11, 2026

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice
07:46

Sub-Retinal Delivery of Human Embryonic Stem Cell Derived Photoreceptor Progenitors in rd10 Mice

Published on: October 6, 2023

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye
05:09

Subretinal Injection of Gene Therapy Vectors and Stem Cells in the Perinatal Mouse Eye

Published on: November 25, 2012

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models
11:29

Defined Xeno-free and Feeder-free Culture Conditions for the Generation of Human iPSC-derived Retinal Cell Models

Published on: September 6, 2018

  • Analysis of practical issues in retinal transplantation surgery.
  • Main Results:

    • Stem and progenitor cells from various sources show potential for generating photoreceptors.
    • Early-stage embryonic or stem cells exhibit limited differentiation into retinal phenotypes post-transplantation.
    • Later-stage donor cells, specifically at the photoreceptor precursor stage, have been successfully transplanted, restoring visual function.

    Conclusions:

    • Understanding developmental cues is crucial for directing stem cell differentiation into photoreceptors for transplantation.
    • Large-scale transplantation of optimally-staged cells is a future goal.
    • Reproductive cloning may enable auto-transplantation of genetically identical stem cells for retinal repair.